• Info
  • Insider Ownership

Insider Trading & Ownership of David Bredt

Location
Boston, MA
Summary
The estimated net worth of David Bredt is at least $10,838,755 dollars as of 16 Jan 2026. David Bredt is the Chief Scientific Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $10.84M.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when David Bredt files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of David Bredt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Scientific Officer $10,838,755 -$1,914,262 -15% 15 Jan 2026

Insider Transactions Reported by David Bredt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.